|
1
|
Kanis JA, McCloskey EV, Johansson H, Oden
A, Melton LJ III and Khaltaev N: A reference standard for the
description of osteoporosis. Bone. 42:467–475. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Teitelbaum SL: Bone resorption by
osteoclasts. Science. 289:1504–1508. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marks SC Jr: The origin of osteoclasts:
Evidence, clinical implications and investigative challenges of an
extra-skeletal source. J Oral Pathol. 12:226–256. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chamberlain G, Fox J, Ashton B and
Middleton J: Concise review: Mesenchymal stem cells: Their
phenotype, differentiation capacity, immunological features, and
potential for homing. Stem Cells. 25:2739–2749. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bianco P, Robey PG, Saggio I and Riminucci
M: 'Mesenchymal' stem cells in human bone marrow (skeletal stem
cells): A critical discussion of their nature, identity, and
significance in incurable skeletal disease. Hum Gene Ther.
21:1057–1066. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Muruganandan S and Sinal CJ: The impact of
bone marrow adipocytes on osteoblast and osteoclast
differentiation. IUBMB Life. 66:147–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Paula FJA and Rosen CJ: Structure and
function of bone marrow adipocytes. Compr Physiol. 8:315–349. 2017.
View Article : Google Scholar
|
|
8
|
Mauney J and Volloch V: Progression of
human bone marrow stromal cells into both osteogenic and adipogenic
lineages is differentially regulated by structural conformation of
collagen I matrix via distinct signaling pathways. Matrix Biol.
28:239–250. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Anderson TJ, Grégoire J, Pearson GJ, Barry
AR, Couture P, Dawes M, Francis GA, Genest J Jr, Grover S, Gupta M,
et al: 2016 Canadian cardiovascular society guidelines for the
management of dyslipidemia for the prevention of cardiovascular
disease in the adult. Can J Cardiol. 32:1263–1282. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shah SR, Werlang CA, Kasper FK and Mikos
AG: Novel applications of statins for bone regeneration. Natl Sci
Rev. 2:85–99. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin TK, Chou P, Lin CH, Hung YJ and Jong
GP: Long-term effect of statins on the risk of new-onset
osteoporosis: A nationwide population-based cohort study. PLoS One.
13:e01967132018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin TK, Liou YS, Lin CH, Chou P and Jong
GP: High-potency statins but not all statins decrease the risk of
new-onset osteoporotic fractures: A nationwide population-based
longitudinal cohort study. Clin Epidemiol. 10:159–165. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moshiri A, Sharifi AM and Oryan A: Role of
Simvastatin on fracture healing and osteoporosis: A systematic
review on in vivo investigations. Clin Exp Pharmacol Physiol.
43:659–684. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jadhav SB and Jain GK: Statins and
osteoporosis: New role for old drugs. J Pharm Pharmacol. 58:3–18.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maritz FJ, Conradie MM, Hulley PA, Gopal R
and Hough S: Effect of statins on bone mineral density and bone
histomorphometry in rodents. Arterioscler Thromb Vasc Biol.
21:1636–1641. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bajaj MS, Kulkarni RS, Ghode SS, Limaye LS
and Kale VP: Irradiation-induced secretion of BMP4 by marrow cells
causes marrow adipogenesis post-myelosuppression. Stem Cell Res.
17:646–653. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu M, Wang K, Tang T, Dai K and Zhu Z:
The effect of simvastatin on the differentiation of marrow stromal
cells from aging rats. Pharmazie. 64:43–48. 2009.PubMed/NCBI
|
|
18
|
Yuan Z, Li Q, Luo S, Liu Z, Luo D, Zhang
B, Zhang D, Rao P and Xiao J: PPARγ and Wnt signaling in adipogenic
and osteogenic differentiation of mesenchymal stem cells. Curr Stem
Cell Res Ther. 11:216–225. 2016. View Article : Google Scholar
|
|
19
|
Harsløf T, Tofteng CL, Husted LB, Nyegaard
M, Børglum A, Carstens M, Stenkjær L, Brixen K, Eiken P, Jensen JE,
et al: Polymorphisms of the peroxisome proliferator-activated
receptor γ (PPARγ) gene are associated with osteoporosis.
Osteoporos Int. 22:2655–2666. 2011. View Article : Google Scholar
|
|
20
|
Muruganandan S, Parlee SD, Rourke JL,
Ernst MC, Goralski KB and Sinal CJ: Chemerin, a novel peroxisome
proliferator-activated receptor gamma (PPARgamma) target gene that
promotes mesenchymal stem cell adipogenesis. J Biol Chem.
286:23982–23995. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mattern A, Zellmann T and Beck-Sickinger
AG: Processing, signaling, and physiological function of chemerin.
IUBMB Life. 66:19–26. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Henau O, Degroot GN, Imbault V, Robert
V, De Poorter C, Mcheik S, Galés C, Parmentier M and Springael JY:
Signaling properties of chemerin receptors CMKLR1, GPR1 and CCRL2.
PLoS One. 11:e01641792016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Helfer G and Wu QF: Chemerin: A
multifaceted adipokine involved in metabolic disorders. J
Endocrinol. 238:R79–R94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kennedy AJ and Davenport AP: International
union of basic and clinical pharmacology CIII: Chemerin receptors
CMKLR1 (Chemerin1) and GPR1 (Chemerin2) nomenclature, pharmacology,
and function. Pharmacol Rev. 70:174–196. 2018. View Article : Google Scholar :
|
|
25
|
Zhao H, Yan D, Xiang L, Huang C, Li J, Yu
X, Huang B, Wang B, Chen J, Xiao T, et al: Chemokine-like receptor
1 deficiency leads to lower bone mass in male mice. Cell Mol Life
Sci. 76:355–367. 2019. View Article : Google Scholar
|
|
26
|
Ramos-Junior ES, Leite GA, Carmo-Silva CC,
Taira TM, Neves KB, Colón DF, da Silva LA, Salvador SL, Tostes RC,
Cunha FQ and Fukada SY: Adipokine chemerin bridges metabolic
dyslipidemia and alveolar bone loss in mice. J Bone Miner Res.
32:974–984. 2017. View Article : Google Scholar
|
|
27
|
Muruganandan S, Govindarajan R, McMullen
NM and Sinal CJ: Chemokine-like receptor 1 is a novel Wnt target
gene that regulates mesenchymal stem cell differentiation. Stem
Cells. 35:711–724. 2017. View Article : Google Scholar
|
|
28
|
Muruganandan S, Roman AA and Sinal CJ:
Role of chemerin/CMKLR1 signaling in adipogenesis and
osteoblastogenesis of bone marrow stem cells. J Bone Miner Res.
25:222–234. 2010. View Article : Google Scholar
|
|
29
|
Goralski KB, McCarthy TC, Hanniman EA,
Zabel BA, Butcher EC, Parlee SD, Muruganandan S and Sinal CJ:
Chemerin, a novel adipokine that regulates adipogenesis and
adipocyte metabolism. J Biol Chem. 282:28175–28188. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
An Q, Wu D, Ma Y, Zhou B and Liu Q:
Suppression of Evi 1 promotes the osteogenic differentiation and
inhibits the adipogenic differentiation of bone marrow-derived
mesenchymal stem cells in vitro. Int J Mol Med. 36:1615–1622. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop DJ and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The international society for cellular
therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schmittgen TD: Real-time quantitative PCR.
Methods. 25:383–385. 2001. View Article : Google Scholar
|
|
33
|
Bedi O, Dhawan V, Sharma PL and Kumar P:
Pleiotropic effects of statins: New therapeutic targets in drug
design. Naunyn Schmiedebergs Arch Pharmacol. 389:695–712. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Roh SG, Song SH, Choi KC, Katoh K,
Wittamer V, Parmentier M and Sasaki S: Chemerin-a new adipokine
that modulates adipogenesis via its own receptor. Biochem Biophys
Res Commun. 362:1013–1018. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao K, Shen Z, Yuan Y, Han D, Song C, Guo
Y and Mei X: Simvastatin inhibits neural cell apoptosis and
promotes locomotor recovery via activation of Wnt/β-catenin
signaling pathway after spinal cord injury. J Neurochem.
138:139–149. 2016. View Article : Google Scholar :
|
|
36
|
Robin NC, Agoston Z, Biechele TL, James
RG, Berndt JD and Moon RT: Simvastatin promotes adult hippocampal
neurogenesis by enhancing Wnt/β-catenin signaling. Stem Cell
Reports. 2:9–17. 2013. View Article : Google Scholar
|
|
37
|
Sawada N and Liao JK: Rho/Rho-associated
coiled-coil forming kinase pathway as therapeutic targets for
statins in atherosclerosis. Antioxid Redox Signal. 20:1251–1267.
2014. View Article : Google Scholar :
|
|
38
|
Rikitake Y and Liao JK: Rho GTPases,
statins, and nitric oxide. Circ Res. 97:1232–1235. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rourke JL, Dranse HJ and Sinal CJ: CMKLR1
and GPR1 mediate chemerin signaling through the RhoA/ROCK pathway.
Mol Cell Endocrinol. 417:36–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang QQ, Otto TC and Lane MD: Mitotic
clonal expansion: A synchronous process required for adipogenesis.
Proc Natl Acad Sci USA. 100:44–49. 2003. View Article : Google Scholar
|
|
41
|
Zanette DL, Lorenzi JC, Panepucci RA,
Palma PV, Dos Santos DF, Prata KL and Silva WA Jr: Simvastatin
modulates mesenchymal stromal cell proliferation and gene
expression. PLoS One. 10:e01201372015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Y, Müller AL, Ngo MA, Sran K, Bellan D,
Arora RC, Kirshenbaum LA and Freed DH: Statins impair survival of
primary human mesenchymal progenitor cells via mevalonate
depletion, NF-κB signaling, and Bnip3. J Cardiovasc Transl Res.
8:96–105. 2015. View Article : Google Scholar
|
|
43
|
Weivoda MM and Hohl RJ: Geranylgeranyl
pyrophosphate stimulates PPARγ expression and adipogenesis through
the inhibition of osteoblast differentiation. Bone. 50:467–476.
2012. View Article : Google Scholar
|
|
44
|
Nicholson AC, Hajjar DP, Zhou X, He W,
Gotto AM Jr and Han J: Anti-adipogenic action of pitavastatin
occurs through the coordinate regulation of PPARgamma and Pref-1
expression. Br J Pharmacol. 151:807–815. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rourke JL, Muruganandan S, Dranse HJ,
McMullen NM and Sinal CJ: Gpr1 is an active chemerin receptor
influencing glucose homeostasis in obese mice. J Endocrinol.
222:201–215. 2014. View Article : Google Scholar : PubMed/NCBI
|
